200 related articles for article (PubMed ID: 11498752)
1. Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.
Voltarelli JC; Ahmed H; Paton EJ; Stracieri AB; Holman P; Bashey A; Coutinho M; Simoes BP; Ball ED; Carrier E
Bone Marrow Transplant; 2001 Jul; 28(1):97-9. PubMed ID: 11498752
[TBL] [Abstract][Full Text] [Related]
2. Koebnerizing sclerodermatous graft-versus-host disease caused by donor lymphocyte infusion and interferon-alpha.
White JM; Devereux S; Pagliuca A; Salisbury JR; du Vivier AW; Creamer D
Br J Dermatol; 2006 Sep; 155(3):621-3. PubMed ID: 16911292
[TBL] [Abstract][Full Text] [Related]
3. Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion.
Skert C; Patriarca F; Zaja F; Tomadini V; Fanin R
Bone Marrow Transplant; 2005 Mar; 35(5):523-4. PubMed ID: 15654352
[No Abstract] [Full Text] [Related]
4. Fatal graft-versus-host disease following HLA-mismatched donor lymphocyte infusion.
Amrolia PJ; Rao K; Slater O; Ramsay A; Veys PA; Webb DK
Bone Marrow Transplant; 2001 Sep; 28(6):623-5. PubMed ID: 11607779
[TBL] [Abstract][Full Text] [Related]
5. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation.
Ma SY; Au WY; Lie AK; Ng IO; Leung AY; Tse EW; Liang RH; Lau GK; Kwong YL
Bone Marrow Transplant; 2004 Jul; 34(1):57-61. PubMed ID: 15156162
[TBL] [Abstract][Full Text] [Related]
6. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.
Tolland JP; Devereux C; Jones FC; Bingham EA
Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
Du B; Li DP; Xu KL; Pan XY
Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
[TBL] [Abstract][Full Text] [Related]
8. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
[TBL] [Abstract][Full Text] [Related]
9. Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease.
Bonanomi S; Balduzzi A; Tagliabue A; Biagi E; Rovelli A; Corti P; Crippa D; Uderzo C
Bone Marrow Transplant; 2001 Sep; 28(6):631-2. PubMed ID: 11607781
[No Abstract] [Full Text] [Related]
10. Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.
Moreno-Romero JA; Fernández-Avilés F; Carreras E; Rovira M; Martínez C; Mascaró JM
Arch Dermatol; 2008 Sep; 144(9):1106-9. PubMed ID: 18794453
[No Abstract] [Full Text] [Related]
11. Tretinoin for the treatment of cutaneous graft-versus-host disease.
Gryn J; Crilley P
Bone Marrow Transplant; 1990 Apr; 5(4):279-80. PubMed ID: 2104506
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of refractory donor lymphocyte infusion-induced immune-mediated pancytopenia with rituximab.
Kato I; Umeda K; Awaya T; Yui Y; Niwa A; Fujino H; Matsubara H; Watanabe K; Heike T; Adachi N; Endo F; Mizukami T; Nunoi H; Nakahata T; Adachi S
Pediatr Blood Cancer; 2010 Feb; 54(2):329-31. PubMed ID: 19890900
[TBL] [Abstract][Full Text] [Related]
13. Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation.
Friedman KJ; LeBoit PE; Farmer ER
Arch Dermatol; 1988 May; 124(5):688-91. PubMed ID: 3284466
[TBL] [Abstract][Full Text] [Related]
14. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
15. [The skin manifestations of the graft vs. host reaction].
Biriukov AV; Baranov AE; Selidovkin GD; Evseeva LV; Getling ZM; Persina IS
Vestn Dermatol Venerol; 1990; (5):16-9. PubMed ID: 2402935
[TBL] [Abstract][Full Text] [Related]
16. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life.
Ziemer M; Thiele JJ; Gruhn B; Elsner P
J Am Acad Dermatol; 2004 Aug; 51(2):318-9. PubMed ID: 15280858
[No Abstract] [Full Text] [Related]
17. Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Mandigers CM; Verdonck LF; Meijerink JP; Dekker AW; Schattenberg AV; Raemaekers JM
Bone Marrow Transplant; 2003 Dec; 32(12):1159-63. PubMed ID: 14647270
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.
Huff CA; Fuchs EJ; Smith BD; Blackford A; Garrett-Mayer E; Brodsky RA; Flinn IW; Ambinder RF; Borrello IM; Matsui WH; Vogelsang GB; Griffin CA; Luznik L; Jones RJ
Biol Blood Marrow Transplant; 2006 Apr; 12(4):414-21. PubMed ID: 16545725
[TBL] [Abstract][Full Text] [Related]
19. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
20. [PUVA therapy for cutaneous acute graft-versus-host disease--a case report].
Inamitsu T; Inoue M; Akiyoshi H; Honda K; Shibuya T; Nakayama H; Ueda K
Rinsho Ketsueki; 1995 Nov; 36(11):1321-5. PubMed ID: 8691576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
